Industry Research Reports

Home > Reports > Pharma & Healthcare > Obsessive-Compulsive Disorder Medicine - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

Obsessive-Compulsive Disorder Medicine - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

Industry: Pharma & Healthcare

Published Date: 2024-02-23

Pages: 139 Pages

Report ld: 2579505

Request Sample

Customized Report

Description
Table of Contents
Table of Figures
Related Reports
PDF Download

Description
Table of Contents
Table of Figures
Related Reports
PDF Download

Obsessive–compulsive disorder (OCD) is a mental disorder in which a person feels the need to perform certain routines repeatedly (called "compulsions"), or has certain thoughts repeatedly (called "obsessions").

The global market for Obsessive-Compulsive Disorder Medicine was estimated to be worth US$ million in 2023 and is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during the forecast period 2024-2030.

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

MARKET SEGMENTATION

By Company

Sun pharmaceuticals industry Ltd.
H.Lunderbeck A/S
Eli Lilly and company
Apotex Inc.
Viatris Inc.
Lannett
GlaxoSmithKline Plc.
Alvogen
Pfizer Inc.
Amneal Pharmaceuticals LLC.
Dr. Reddy's Laboratories Ltd.
Abbott
Par Pharmaceuticals
Sebela Pharmaceuticals
Mallinckrodt
Lupin

Consumption by Region

North America
- United States
- Canada
Asia-Pacific
- China
- Japan
- South Korea
- Southeast Asia
- India
- Australia
- Rest of Asia-Pacific
Europe
- Germany
- France
- U.K.
- Italy
- Netherlands
- Nordic Countries
- Rest of Europe
Latin America
- Mexico
- Brazil
- Rest of Latin America
Middle East & Africa
- Turkey
- Saudi Arabia
- UAE
- Rest of MEA

Segment by Type

NMDA Receptor Blockers
Antipsychotics
Antidepressants

Segment by Application

Hospitals
Homecare
Clinics
Others

biaoTi REPORT SCOPE

This report aims to provide a comprehensive presentation of the global market for Obsessive-Compulsive Disorder Medicine, focusing on the total sales volume, sales revenue, price, key companies market share and ranking, together with an analysis of Obsessive-Compulsive Disorder Medicine by region & country, by Type, and by Application.

The Obsessive-Compulsive Disorder Medicine market size, estimations, and forecasts are provided in terms of sales volume (K Units) and sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Obsessive-Compulsive Disorder Medicine.

biaoTi CHAPTER OUTLINE

Chapter 1: Introduces the report scope of the report, global total market size (valve, volume and price). This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 2: Detailed analysis of Obsessive-Compulsive Disorder Medicine manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 5: Sales, revenue of Obsessive-Compulsive Disorder Medicine in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 6: Sales, revenue of Obsessive-Compulsive Disorder Medicine in country level. It provides sigmate data by Type, and by Application for each country/region.

Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 9: Conclusion.

biaoTi QYRESEARCH'S STRENGTHS

Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:

Market entry risks/opportunities by region

We identify regional market threats and growth prospects to guide your overseas layout.

Product mix optimization based on local practices

We adjust product portfolios in line with local consumption habits.

Competitor tactics in fragmented vs. consolidated markets

We unpack rivals’ operation strategies for scattered and highly concentrated industries.

Full Research Coverage

We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.

19 Years Industry Expertise

We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.

24/7 Fast Report Delivery

Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.

Localized Strategic Analysis

We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.

Market entry risks/opportunities by region

All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.

Market entry risks/opportunities by region

We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.

TABLE OF CONTENTS

1 Market Overview

1.1 Obsessive-Compulsive Disorder Medicine Product Introduction

1.2 Global Obsessive-Compulsive Disorder Medicine Market Size Forecast

1.2.1 Global Obsessive-Compulsive Disorder Medicine Sales Value (2019-2030)

1.2.2 Global Obsessive-Compulsive Disorder Medicine Sales Volume (2019-2030)

1.2.3 Global Obsessive-Compulsive Disorder Medicine Sales Price (2019-2030)

1.3 Obsessive-Compulsive Disorder Medicine Market Trends & Drivers

1.3.1 Obsessive-Compulsive Disorder Medicine Industry Trends

1.3.2 Obsessive-Compulsive Disorder Medicine Market Drivers & Opportunity

1.3.3 Obsessive-Compulsive Disorder Medicine Market Challenges

1.3.4 Obsessive-Compulsive Disorder Medicine Market Restraints

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Competitive Analysis by Company

2.1 Global Obsessive-Compulsive Disorder Medicine Players Revenue Ranking (2023)

2.2 Global Obsessive-Compulsive Disorder Medicine Revenue by Company (2019-2024)

2.3 Global Obsessive-Compulsive Disorder Medicine Players Sales Volume Ranking (2023)

2.4 Global Obsessive-Compulsive Disorder Medicine Sales Volume by Company Players (2019-2024)

2.5 Global Obsessive-Compulsive Disorder Medicine Average Price by Company (2019-2024)

2.6 Key Manufacturers Obsessive-Compulsive Disorder Medicine Manufacturing Base Distribution and Headquarters

2.7 Key Manufacturers Obsessive-Compulsive Disorder Medicine Product Offered

2.8 Key Manufacturers Time to Begin Mass Production of Obsessive-Compulsive Disorder Medicine

2.9 Obsessive-Compulsive Disorder Medicine Market Competitive Analysis

2.9.1 Obsessive-Compulsive Disorder Medicine Market Concentration Rate (2019-2024)

2.9.2 Global 5 and 10 Largest Manufacturers by Obsessive-Compulsive Disorder Medicine Revenue in 2023

2.9.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Obsessive-Compulsive Disorder Medicine as of 2023)

2.10 Mergers & Acquisitions, Expansion

3 Segmentation by Type

3.1 Introduction by Type

3.1.1 NMDA Receptor Blockers

3.1.2 Antipsychotics

3.1.3 Antidepressants

3.2 Global Obsessive-Compulsive Disorder Medicine Sales Value by Type

3.2.1 Global Obsessive-Compulsive Disorder Medicine Sales Value by Type (2019 VS 2023 VS 2030)

3.2.2 Global Obsessive-Compulsive Disorder Medicine Sales Value, by Type (2019-2030)

3.2.3 Global Obsessive-Compulsive Disorder Medicine Sales Value, by Type (%) (2019-2030)

3.3 Global Obsessive-Compulsive Disorder Medicine Sales Volume by Type

3.3.1 Global Obsessive-Compulsive Disorder Medicine Sales Volume by Type (2019 VS 2023 VS 2030)

3.3.2 Global Obsessive-Compulsive Disorder Medicine Sales Volume, by Type (2019-2030)

3.3.3 Global Obsessive-Compulsive Disorder Medicine Sales Volume, by Type (%) (2019-2030)

3.4 Global Obsessive-Compulsive Disorder Medicine Average Price by Type (2019-2030)

4 Segmentation by Application

4.1 Introduction by Application

4.1.1 Hospitals

4.1.2 Homecare

4.1.3 Clinics

4.1.4 Others

4.2 Global Obsessive-Compulsive Disorder Medicine Sales Value by Application

4.2.1 Global Obsessive-Compulsive Disorder Medicine Sales Value by Application (2019 VS 2023 VS 2030)

4.2.2 Global Obsessive-Compulsive Disorder Medicine Sales Value, by Application (2019-2030)

4.2.3 Global Obsessive-Compulsive Disorder Medicine Sales Value, by Application (%) (2019-2030)

4.3 Global Obsessive-Compulsive Disorder Medicine Sales Volume by Application

4.3.1 Global Obsessive-Compulsive Disorder Medicine Sales Volume by Application (2019 VS 2023 VS 2030)

4.3.2 Global Obsessive-Compulsive Disorder Medicine Sales Volume, by Application (2019-2030)

4.3.3 Global Obsessive-Compulsive Disorder Medicine Sales Volume, by Application (%) (2019-2030)

4.4 Global Obsessive-Compulsive Disorder Medicine Average Price by Application (2019-2030)

5 Segmentation by Region

5.1 Global Obsessive-Compulsive Disorder Medicine Sales Value by Region

5.1.1 Global Obsessive-Compulsive Disorder Medicine Sales Value by Region: 2019 VS 2023 VS 2030

5.1.2 Global Obsessive-Compulsive Disorder Medicine Sales Value by Region (2019-2024)

5.1.3 Global Obsessive-Compulsive Disorder Medicine Sales Value by Region (2025-2030)

5.1.4 Global Obsessive-Compulsive Disorder Medicine Sales Value by Region (%), (2019-2030)

5.2 Global Obsessive-Compulsive Disorder Medicine Sales Volume by Region

5.2.1 Global Obsessive-Compulsive Disorder Medicine Sales Volume by Region: 2019 VS 2023 VS 2030

5.2.2 Global Obsessive-Compulsive Disorder Medicine Sales Volume by Region (2019-2024)

5.2.3 Global Obsessive-Compulsive Disorder Medicine Sales Volume by Region (2025-2030)

5.2.4 Global Obsessive-Compulsive Disorder Medicine Sales Volume by Region (%), (2019-2030)

5.3 Global Obsessive-Compulsive Disorder Medicine Average Price by Region (2019-2030)

5.4 North America

5.4.1 North America Obsessive-Compulsive Disorder Medicine Sales Value, 2019-2030

5.4.2 North America Obsessive-Compulsive Disorder Medicine Sales Value by Country (%), 2023 VS 2030

5.5 Europe

5.5.1 Europe Obsessive-Compulsive Disorder Medicine Sales Value, 2019-2030

5.5.2 Europe Obsessive-Compulsive Disorder Medicine Sales Value by Country (%), 2023 VS 2030

5.6 Asia Pacific

5.6.1 Asia Pacific Obsessive-Compulsive Disorder Medicine Sales Value, 2019-2030

5.6.2 Asia Pacific Obsessive-Compulsive Disorder Medicine Sales Value by Country (%), 2023 VS 2030

5.7 South America

5.7.1 South America Obsessive-Compulsive Disorder Medicine Sales Value, 2019-2030

5.7.2 South America Obsessive-Compulsive Disorder Medicine Sales Value by Country (%), 2023 VS 2030

5.8 Middle East & Africa

5.8.1 Middle East & Africa Obsessive-Compulsive Disorder Medicine Sales Value, 2019-2030

5.8.2 Middle East & Africa Obsessive-Compulsive Disorder Medicine Sales Value by Country (%), 2023 VS 2030

6 Segmentation by Key Countries/Regions

6.1 Key Countries/Regions Obsessive-Compulsive Disorder Medicine Sales Value Growth Trends, 2019 VS 2023 VS 2030

6.2 Key Countries/Regions Obsessive-Compulsive Disorder Medicine Sales Value

6.2.1 Key Countries/Regions Obsessive-Compulsive Disorder Medicine Sales Value, 2019-2030

6.2.2 Key Countries/Regions Obsessive-Compulsive Disorder Medicine Sales Volume, 2019-2030

6.3 United States

6.3.1 United States Obsessive-Compulsive Disorder Medicine Sales Value, 2019-2030

6.3.2 United States Obsessive-Compulsive Disorder Medicine Sales Value by Type (%), 2023 VS 2030

6.3.3 United States Obsessive-Compulsive Disorder Medicine Sales Value by Application, 2023 VS 2030

6.4 Europe

6.4.1 Europe Obsessive-Compulsive Disorder Medicine Sales Value, 2019-2030

6.4.2 Europe Obsessive-Compulsive Disorder Medicine Sales Value by Type (%), 2023 VS 2030

6.4.3 Europe Obsessive-Compulsive Disorder Medicine Sales Value by Application, 2023 VS 2030

6.5 China

6.5.1 China Obsessive-Compulsive Disorder Medicine Sales Value, 2019-2030

6.5.2 China Obsessive-Compulsive Disorder Medicine Sales Value by Type (%), 2023 VS 2030

6.5.3 China Obsessive-Compulsive Disorder Medicine Sales Value by Application, 2023 VS 2030

6.6 Japan

6.6.1 Japan Obsessive-Compulsive Disorder Medicine Sales Value, 2019-2030

6.6.2 Japan Obsessive-Compulsive Disorder Medicine Sales Value by Type (%), 2023 VS 2030

6.6.3 Japan Obsessive-Compulsive Disorder Medicine Sales Value by Application, 2023 VS 2030

6.7 South Korea

6.7.1 South Korea Obsessive-Compulsive Disorder Medicine Sales Value, 2019-2030

6.7.2 South Korea Obsessive-Compulsive Disorder Medicine Sales Value by Type (%), 2023 VS 2030

6.7.3 South Korea Obsessive-Compulsive Disorder Medicine Sales Value by Application, 2023 VS 2030

6.8 Southeast Asia

6.8.1 Southeast Asia Obsessive-Compulsive Disorder Medicine Sales Value, 2019-2030

6.8.2 Southeast Asia Obsessive-Compulsive Disorder Medicine Sales Value by Type (%), 2023 VS 2030

6.8.3 Southeast Asia Obsessive-Compulsive Disorder Medicine Sales Value by Application, 2023 VS 2030

6.9 India

6.9.1 India Obsessive-Compulsive Disorder Medicine Sales Value, 2019-2030

6.9.2 India Obsessive-Compulsive Disorder Medicine Sales Value by Type (%), 2023 VS 2030

6.9.3 India Obsessive-Compulsive Disorder Medicine Sales Value by Application, 2023 VS 2030

7 Company Profiles

7.1 Sun pharmaceuticals industry Ltd.

7.1.1 Sun pharmaceuticals industry Ltd. Company Information

7.1.2 Sun pharmaceuticals industry Ltd. Introduction and Business Overview

7.1.3 Sun pharmaceuticals industry Ltd. Obsessive-Compulsive Disorder Medicine Sales, Revenue and Gross Margin (2019-2024)

7.1.4 Sun pharmaceuticals industry Ltd. Obsessive-Compulsive Disorder Medicine Product Offerings

7.1.5 Sun pharmaceuticals industry Ltd. Recent Development

7.2 H.Lunderbeck A/S

7.2.1 H.Lunderbeck A/S Company Information

7.2.2 H.Lunderbeck A/S Introduction and Business Overview

7.2.3 H.Lunderbeck A/S Obsessive-Compulsive Disorder Medicine Sales, Revenue and Gross Margin (2019-2024)

7.2.4 H.Lunderbeck A/S Obsessive-Compulsive Disorder Medicine Product Offerings

7.2.5 H.Lunderbeck A/S Recent Development

7.3 Eli Lilly and company

7.3.1 Eli Lilly and company Company Information

7.3.2 Eli Lilly and company Introduction and Business Overview

7.3.3 Eli Lilly and company Obsessive-Compulsive Disorder Medicine Sales, Revenue and Gross Margin (2019-2024)

7.3.4 Eli Lilly and company Obsessive-Compulsive Disorder Medicine Product Offerings

7.3.5 Eli Lilly and company Recent Development

7.4 Apotex Inc.

7.4.1 Apotex Inc. Company Information

7.4.2 Apotex Inc. Introduction and Business Overview

7.4.3 Apotex Inc. Obsessive-Compulsive Disorder Medicine Sales, Revenue and Gross Margin (2019-2024)

7.4.4 Apotex Inc. Obsessive-Compulsive Disorder Medicine Product Offerings

7.4.5 Apotex Inc. Recent Development

7.5 Viatris Inc.

7.5.1 Viatris Inc. Company Information

7.5.2 Viatris Inc. Introduction and Business Overview

7.5.3 Viatris Inc. Obsessive-Compulsive Disorder Medicine Sales, Revenue and Gross Margin (2019-2024)

7.5.4 Viatris Inc. Obsessive-Compulsive Disorder Medicine Product Offerings

7.5.5 Viatris Inc. Recent Development

7.6 Lannett

7.6.1 Lannett Company Information

7.6.2 Lannett Introduction and Business Overview

7.6.3 Lannett Obsessive-Compulsive Disorder Medicine Sales, Revenue and Gross Margin (2019-2024)

7.6.4 Lannett Obsessive-Compulsive Disorder Medicine Product Offerings

7.6.5 Lannett Recent Development

7.7 GlaxoSmithKline Plc.

7.7.1 GlaxoSmithKline Plc. Company Information

7.7.2 GlaxoSmithKline Plc. Introduction and Business Overview

7.7.3 GlaxoSmithKline Plc. Obsessive-Compulsive Disorder Medicine Sales, Revenue and Gross Margin (2019-2024)

7.7.4 GlaxoSmithKline Plc. Obsessive-Compulsive Disorder Medicine Product Offerings

7.7.5 GlaxoSmithKline Plc. Recent Development

7.8 Alvogen

7.8.1 Alvogen Company Information

7.8.2 Alvogen Introduction and Business Overview

7.8.3 Alvogen Obsessive-Compulsive Disorder Medicine Sales, Revenue and Gross Margin (2019-2024)

7.8.4 Alvogen Obsessive-Compulsive Disorder Medicine Product Offerings

7.8.5 Alvogen Recent Development

7.9 Pfizer Inc.

7.9.1 Pfizer Inc. Company Information

7.9.2 Pfizer Inc. Introduction and Business Overview

7.9.3 Pfizer Inc. Obsessive-Compulsive Disorder Medicine Sales, Revenue and Gross Margin (2019-2024)

7.9.4 Pfizer Inc. Obsessive-Compulsive Disorder Medicine Product Offerings

7.9.5 Pfizer Inc. Recent Development

7.10 Amneal Pharmaceuticals LLC.

7.10.1 Amneal Pharmaceuticals LLC. Company Information

7.10.2 Amneal Pharmaceuticals LLC. Introduction and Business Overview

7.10.3 Amneal Pharmaceuticals LLC. Obsessive-Compulsive Disorder Medicine Sales, Revenue and Gross Margin (2019-2024)

7.10.4 Amneal Pharmaceuticals LLC. Obsessive-Compulsive Disorder Medicine Product Offerings

7.10.5 Amneal Pharmaceuticals LLC. Recent Development

7.11 Dr. Reddy's Laboratories Ltd.

7.11.1 Dr. Reddy's Laboratories Ltd. Company Information

7.11.2 Dr. Reddy's Laboratories Ltd. Introduction and Business Overview

7.11.3 Dr. Reddy's Laboratories Ltd. Obsessive-Compulsive Disorder Medicine Sales, Revenue and Gross Margin (2019-2024)

7.11.4 Dr. Reddy's Laboratories Ltd. Obsessive-Compulsive Disorder Medicine Product Offerings

7.11.5 Dr. Reddy's Laboratories Ltd. Recent Development

7.12 Abbott

7.12.1 Abbott Company Information

7.12.2 Abbott Introduction and Business Overview

7.12.3 Abbott Obsessive-Compulsive Disorder Medicine Sales, Revenue and Gross Margin (2019-2024)

7.12.4 Abbott Obsessive-Compulsive Disorder Medicine Product Offerings

7.12.5 Abbott Recent Development

7.13 Par Pharmaceuticals

7.13.1 Par Pharmaceuticals Company Information

7.13.2 Par Pharmaceuticals Introduction and Business Overview

7.13.3 Par Pharmaceuticals Obsessive-Compulsive Disorder Medicine Sales, Revenue and Gross Margin (2019-2024)

7.13.4 Par Pharmaceuticals Obsessive-Compulsive Disorder Medicine Product Offerings

7.13.5 Par Pharmaceuticals Recent Development

7.14 Sebela Pharmaceuticals

7.14.1 Sebela Pharmaceuticals Company Information

7.14.2 Sebela Pharmaceuticals Introduction and Business Overview

7.14.3 Sebela Pharmaceuticals Obsessive-Compulsive Disorder Medicine Sales, Revenue and Gross Margin (2019-2024)

7.14.4 Sebela Pharmaceuticals Obsessive-Compulsive Disorder Medicine Product Offerings

7.14.5 Sebela Pharmaceuticals Recent Development

7.15 Mallinckrodt

7.15.1 Mallinckrodt Company Information

7.15.2 Mallinckrodt Introduction and Business Overview

7.15.3 Mallinckrodt Obsessive-Compulsive Disorder Medicine Sales, Revenue and Gross Margin (2019-2024)

7.15.4 Mallinckrodt Obsessive-Compulsive Disorder Medicine Product Offerings

7.15.5 Mallinckrodt Recent Development

7.16 Lupin

7.16.1 Lupin Company Information

7.16.2 Lupin Introduction and Business Overview

7.16.3 Lupin Obsessive-Compulsive Disorder Medicine Sales, Revenue and Gross Margin (2019-2024)

7.16.4 Lupin Obsessive-Compulsive Disorder Medicine Product Offerings

7.16.5 Lupin Recent Development

8 Industry Chain Analysis

8.1 Obsessive-Compulsive Disorder Medicine Industrial Chain

8.2 Obsessive-Compulsive Disorder Medicine Upstream Analysis

8.2.1 Key Raw Materials

8.2.2 Raw Materials Key Suppliers

8.2.3 Manufacturing Cost Structure

8.3 Midstream Analysis

8.4 Downstream Analysis (Customers Analysis)

8.5 Sales Model and Sales Channels

8.5.1 Obsessive-Compulsive Disorder Medicine Sales Model

8.5.2 Sales Channel

8.5.3 Obsessive-Compulsive Disorder Medicine Distributors

9 Research Findings and Conclusion

10 Appendix

10.1 Research Methodology

10.1.1 Methodology/Research Approach

10.1.2 Data Source

10.2 Author Details

10.3 Disclaimer

TABLE OF FIGURES

List of Tables

Table 1. Obsessive-Compulsive Disorder Medicine Market Trends

Table 2. Obsessive-Compulsive Disorder Medicine Market Drivers & Opportunity

Table 3. Obsessive-Compulsive Disorder Medicine Market Challenges

Table 4. Obsessive-Compulsive Disorder Medicine Market Restraints

Table 5. Global Obsessive-Compulsive Disorder Medicine Revenue by Company (2019-2024) & (US$ Million)

Table 6. Global Obsessive-Compulsive Disorder Medicine Revenue Market Share by Company (2019-2024)

Table 7. Global Obsessive-Compulsive Disorder Medicine Sales Volume by Company (2019-2024) & (K Units)

Table 8. Global Obsessive-Compulsive Disorder Medicine Sales Volume Market Share by Company (2019-2024)

Table 9. Global Market Obsessive-Compulsive Disorder Medicine Price by Company (2019-2024) & (USD/Unit)

Table 10. Key Manufacturers Obsessive-Compulsive Disorder Medicine Manufacturing Base Distribution and Headquarters

Table 11. Key Manufacturers Obsessive-Compulsive Disorder Medicine Product Type

Table 12. Key Manufacturers Time to Begin Mass Production of Obsessive-Compulsive Disorder Medicine

Table 13. Global Obsessive-Compulsive Disorder Medicine Manufacturers Market Concentration Ratio (CR5 and HHI)

Table 14. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Obsessive-Compulsive Disorder Medicine as of 2023)

Table 15. Mergers & Acquisitions, Expansion Plans

Table 16. Global Obsessive-Compulsive Disorder Medicine Sales Value by Type: 2019 VS 2023 VS 2030 (US$ Million)

Table 17. Global Obsessive-Compulsive Disorder Medicine Sales Value by Type (2019-2024) & (US$ Million)

Table 18. Global Obsessive-Compulsive Disorder Medicine Sales Value by Type (2025-2030) & (US$ Million)

Table 19. Global Obsessive-Compulsive Disorder Medicine Sales Market Share in Value by Type (2019-2024) & (%)

Table 20. Global Obsessive-Compulsive Disorder Medicine Sales Market Share in Value by Type (2025-2030) & (%)

Table 21. Global Obsessive-Compulsive Disorder Medicine Sales Volume by Type: 2019 VS 2023 VS 2030 (K Units)

Table 22. Global Obsessive-Compulsive Disorder Medicine Sales Volume by Type (2019-2024) & (K Units)

Table 23. Global Obsessive-Compulsive Disorder Medicine Sales Volume by Type (2025-2030) & (K Units)

Table 24. Global Obsessive-Compulsive Disorder Medicine Sales Market Share in Volume by Type (2019-2024) & (%)

Table 25. Global Obsessive-Compulsive Disorder Medicine Sales Market Share in Volume by Type (2025-2030) & (%)

Table 26. Global Obsessive-Compulsive Disorder Medicine Price by Type (2019-2024) & (USD/Unit)

Table 27. Global Obsessive-Compulsive Disorder Medicine Price by Type (2025-2030) & (USD/Unit)

Table 28. Global Obsessive-Compulsive Disorder Medicine Sales Value by Application: 2019 VS 2023 VS 2030 (US$ Million)

Table 29. Global Obsessive-Compulsive Disorder Medicine Sales Value by Application (2019-2024) & (US$ Million)

Table 30. Global Obsessive-Compulsive Disorder Medicine Sales Value by Application (2025-2030) & (US$ Million)

Table 31. Global Obsessive-Compulsive Disorder Medicine Sales Market Share in Value by Application (2019-2024) & (%)

Table 32. Global Obsessive-Compulsive Disorder Medicine Sales Market Share in Value by Application (2025-2030) & (%)

Table 33. Global Obsessive-Compulsive Disorder Medicine Sales Volume by Application: 2019 VS 2023 VS 2030 (K Units)

Table 34. Global Obsessive-Compulsive Disorder Medicine Sales Volume by Application (2019-2024) & (K Units)

Table 35. Global Obsessive-Compulsive Disorder Medicine Sales Volume by Application (2025-2030) & (K Units)

Table 36. Global Obsessive-Compulsive Disorder Medicine Sales Market Share in Volume by Application (2019-2024) & (%)

Table 37. Global Obsessive-Compulsive Disorder Medicine Sales Market Share in Volume by Application (2025-2030) & (%)

Table 38. Global Obsessive-Compulsive Disorder Medicine Price by Application (2019-2024) & (USD/Unit)

Table 39. Global Obsessive-Compulsive Disorder Medicine Price by Application (2025-2030) & (USD/Unit)

Table 40. Global Obsessive-Compulsive Disorder Medicine Sales Value by Region: 2019 VS 2023 VS 2030 (US$ Million)

Table 41. Global Obsessive-Compulsive Disorder Medicine Sales Value by Region (2019-2024) & (US$ Million)

Table 42. Global Obsessive-Compulsive Disorder Medicine Sales Value by Region (2025-2030) & (US$ Million)

Table 43. Global Obsessive-Compulsive Disorder Medicine Sales Value by Region (2019-2024) & (%)

Table 44. Global Obsessive-Compulsive Disorder Medicine Sales Value by Region (2025-2030) & (%)

Table 45. Global Obsessive-Compulsive Disorder Medicine Sales Volume by Region (K Units): 2019 VS 2023 VS 2030

Table 46. Global Obsessive-Compulsive Disorder Medicine Sales Volume by Region (2019-2024) & (K Units)

Table 47. Global Obsessive-Compulsive Disorder Medicine Sales Volume by Region (2025-2030) & (K Units)

Table 48. Global Obsessive-Compulsive Disorder Medicine Sales Volume by Region (2019-2024) & (%)

Table 49. Global Obsessive-Compulsive Disorder Medicine Sales Volume by Region (2025-2030) & (%)

Table 50. Global Obsessive-Compulsive Disorder Medicine Average Price by Region (2019-2024) & (USD/Unit)

Table 51. Global Obsessive-Compulsive Disorder Medicine Average Price by Region (2025-2030) & (USD/Unit)

Table 52. Key Countries/Regions Obsessive-Compulsive Disorder Medicine Sales Value Growth Trends, (US$ Million): 2019 VS 2023 VS 2030

Table 53. Key Countries/Regions Obsessive-Compulsive Disorder Medicine Sales Value, (2019-2024) & (US$ Million)

Table 54. Key Countries/Regions Obsessive-Compulsive Disorder Medicine Sales Value, (2025-2030) & (US$ Million)

Table 55. Key Countries/Regions Obsessive-Compulsive Disorder Medicine Sales Volume, (2019-2024) & (K Units)

Table 56. Key Countries/Regions Obsessive-Compulsive Disorder Medicine Sales Volume, (2025-2030) & (K Units)

Table 57. Sun pharmaceuticals industry Ltd. Company Information

Table 58. Sun pharmaceuticals industry Ltd. Introduction and Business Overview

Table 59. Sun pharmaceuticals industry Ltd. Obsessive-Compulsive Disorder Medicine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)

Table 60. Sun pharmaceuticals industry Ltd. Obsessive-Compulsive Disorder Medicine Product Offerings

Table 61. Sun pharmaceuticals industry Ltd. Recent Development

Table 62. H.Lunderbeck A/S Company Information

Table 63. H.Lunderbeck A/S Introduction and Business Overview

Table 64. H.Lunderbeck A/S Obsessive-Compulsive Disorder Medicine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)

Table 65. H.Lunderbeck A/S Obsessive-Compulsive Disorder Medicine Product Offerings

Table 66. H.Lunderbeck A/S Recent Development

Table 67. Eli Lilly and company Company Information

Table 68. Eli Lilly and company Introduction and Business Overview

Table 69. Eli Lilly and company Obsessive-Compulsive Disorder Medicine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)

Table 70. Eli Lilly and company Obsessive-Compulsive Disorder Medicine Product Offerings

Table 71. Eli Lilly and company Recent Development

Table 72. Apotex Inc. Company Information

Table 73. Apotex Inc. Introduction and Business Overview

Table 74. Apotex Inc. Obsessive-Compulsive Disorder Medicine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)

Table 75. Apotex Inc. Obsessive-Compulsive Disorder Medicine Product Offerings

Table 76. Apotex Inc. Recent Development

Table 77. Viatris Inc. Company Information

Table 78. Viatris Inc. Introduction and Business Overview

Table 79. Viatris Inc. Obsessive-Compulsive Disorder Medicine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)

Table 80. Viatris Inc. Obsessive-Compulsive Disorder Medicine Product Offerings

Table 81. Viatris Inc. Recent Development

Table 82. Lannett Company Information

Table 83. Lannett Introduction and Business Overview

Table 84. Lannett Obsessive-Compulsive Disorder Medicine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)

Table 85. Lannett Obsessive-Compulsive Disorder Medicine Product Offerings

Table 86. Lannett Recent Development

Table 87. GlaxoSmithKline Plc. Company Information

Table 88. GlaxoSmithKline Plc. Introduction and Business Overview

Table 89. GlaxoSmithKline Plc. Obsessive-Compulsive Disorder Medicine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)

Table 90. GlaxoSmithKline Plc. Obsessive-Compulsive Disorder Medicine Product Offerings

Table 91. GlaxoSmithKline Plc. Recent Development

Table 92. Alvogen Company Information

Table 93. Alvogen Introduction and Business Overview

Table 94. Alvogen Obsessive-Compulsive Disorder Medicine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)

Table 95. Alvogen Obsessive-Compulsive Disorder Medicine Product Offerings

Table 96. Alvogen Recent Development

Table 97. Pfizer Inc. Company Information

Table 98. Pfizer Inc. Introduction and Business Overview

Table 99. Pfizer Inc. Obsessive-Compulsive Disorder Medicine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)

Table 100. Pfizer Inc. Obsessive-Compulsive Disorder Medicine Product Offerings

Table 101. Pfizer Inc. Recent Development

Table 102. Amneal Pharmaceuticals LLC. Company Information

Table 103. Amneal Pharmaceuticals LLC. Introduction and Business Overview

Table 104. Amneal Pharmaceuticals LLC. Obsessive-Compulsive Disorder Medicine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)

Table 105. Amneal Pharmaceuticals LLC. Obsessive-Compulsive Disorder Medicine Product Offerings

Table 106. Amneal Pharmaceuticals LLC. Recent Development

Table 107. Dr. Reddy's Laboratories Ltd. Company Information

Table 108. Dr. Reddy's Laboratories Ltd. Introduction and Business Overview

Table 109. Dr. Reddy's Laboratories Ltd. Obsessive-Compulsive Disorder Medicine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)

Table 110. Dr. Reddy's Laboratories Ltd. Obsessive-Compulsive Disorder Medicine Product Offerings

Table 111. Dr. Reddy's Laboratories Ltd. Recent Development

Table 112. Abbott Company Information

Table 113. Abbott Introduction and Business Overview

Table 114. Abbott Obsessive-Compulsive Disorder Medicine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)

Table 115. Abbott Obsessive-Compulsive Disorder Medicine Product Offerings

Table 116. Abbott Recent Development

Table 117. Par Pharmaceuticals Company Information

Table 118. Par Pharmaceuticals Introduction and Business Overview

Table 119. Par Pharmaceuticals Obsessive-Compulsive Disorder Medicine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)

Table 120. Par Pharmaceuticals Obsessive-Compulsive Disorder Medicine Product Offerings

Table 121. Par Pharmaceuticals Recent Development

Table 122. Sebela Pharmaceuticals Company Information

Table 123. Sebela Pharmaceuticals Introduction and Business Overview

Table 124. Sebela Pharmaceuticals Obsessive-Compulsive Disorder Medicine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)

Table 125. Sebela Pharmaceuticals Obsessive-Compulsive Disorder Medicine Product Offerings

Table 126. Sebela Pharmaceuticals Recent Development

Table 127. Mallinckrodt Company Information

Table 128. Mallinckrodt Introduction and Business Overview

Table 129. Mallinckrodt Obsessive-Compulsive Disorder Medicine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)

Table 130. Mallinckrodt Obsessive-Compulsive Disorder Medicine Product Offerings

Table 131. Mallinckrodt Recent Development

Table 132. Lupin Company Information

Table 133. Lupin Introduction and Business Overview

Table 134. Lupin Obsessive-Compulsive Disorder Medicine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)

Table 135. Lupin Obsessive-Compulsive Disorder Medicine Product Offerings

Table 136. Lupin Recent Development

Table 137. Key Raw Materials Lists

Table 138. Raw Materials Key Suppliers Lists

Table 139. Obsessive-Compulsive Disorder Medicine Downstream Customers

Table 140. Obsessive-Compulsive Disorder Medicine Distributors List

Table 141. Research Programs/Design for This Report

Table 142. Key Data Information from Secondary Sources

Table 143. Key Data Information from Primary Sources

List of Figures

Figure 1. Obsessive-Compulsive Disorder Medicine Product Picture

Figure 2. Global Obsessive-Compulsive Disorder Medicine Sales Value, 2019 VS 2023 VS 2030 (US$ Million)

Figure 3. Global Obsessive-Compulsive Disorder Medicine Sales Value (2019-2030) & (US$ Million)

Figure 4. Global Obsessive-Compulsive Disorder Medicine Sales Volume (2019-2030) & (K Units)

Figure 5. Global Obsessive-Compulsive Disorder Medicine Sales Price (2019-2030) & (USD/Unit)

Figure 6. Obsessive-Compulsive Disorder Medicine Report Years Considered

Figure 7. Global Obsessive-Compulsive Disorder Medicine Players Revenue Ranking (2023) & (US$ Million)

Figure 8. Global Obsessive-Compulsive Disorder Medicine Players Sales Volume Ranking (2023) & (K Units)

Figure 9. The 5 and 10 Largest Manufacturers in the World: Market Share by Obsessive-Compulsive Disorder Medicine Revenue in 2023

Figure 10. Obsessive-Compulsive Disorder Medicine Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023

Figure 11. NMDA Receptor Blockers Picture

Figure 12. Antipsychotics Picture

Figure 13. Antidepressants Picture

Figure 14. Global Obsessive-Compulsive Disorder Medicine Sales Value by Type (2019 VS 2023 VS 2030) & (US$ Million)

Figure 15. Global Obsessive-Compulsive Disorder Medicine Sales Value Market Share by Type, 2023 & 2030

Figure 16. Global Obsessive-Compulsive Disorder Medicine Sales Volume by Type (2019 VS 2023 VS 2030) & (K Units)

Figure 17. Global Obsessive-Compulsive Disorder Medicine Sales Volume Market Share by Type, 2023 & 2030

Figure 18. Global Obsessive-Compulsive Disorder Medicine Price by Type (2019-2030) & (USD/Unit)

Figure 19. Product Picture of Hospitals

Figure 20. Product Picture of Homecare

Figure 21. Product Picture of Clinics

Figure 22. Product Picture of Others

Figure 23. Global Obsessive-Compulsive Disorder Medicine Sales Value by Application (2019 VS 2023 VS 2030) & (US$ Million)

Figure 24. Global Obsessive-Compulsive Disorder Medicine Sales Value Market Share by Application, 2023 & 2030

Figure 25. Global Obsessive-Compulsive Disorder Medicine Sales Volume by Application (2019 VS 2023 VS 2030) & (K Units)

Figure 26. Global Obsessive-Compulsive Disorder Medicine Sales Volume Market Share by Application, 2023 & 2030

Figure 27. Global Obsessive-Compulsive Disorder Medicine Price by Application (2019-2030) & (USD/Unit)

Figure 28. North America Obsessive-Compulsive Disorder Medicine Sales Value (2019-2030) & (US$ Million)

Figure 29. North America Obsessive-Compulsive Disorder Medicine Sales Value by Country (%), 2023 VS 2030

Figure 30. Europe Obsessive-Compulsive Disorder Medicine Sales Value (2019-2030) & (US$ Million)

Figure 31. Europe Obsessive-Compulsive Disorder Medicine Sales Value by Country (%), 2023 VS 2030

Figure 32. Asia Pacific Obsessive-Compulsive Disorder Medicine Sales Value (2019-2030) & (US$ Million)

Figure 33. Asia Pacific Obsessive-Compulsive Disorder Medicine Sales Value by Country (%), 2023 VS 2030

Figure 34. South America Obsessive-Compulsive Disorder Medicine Sales Value (2019-2030) & (US$ Million)

Figure 35. South America Obsessive-Compulsive Disorder Medicine Sales Value by Country (%), 2023 VS 2030

Figure 36. Middle East & Africa Obsessive-Compulsive Disorder Medicine Sales Value (2019-2030) & (US$ Million)

Figure 37. Middle East & Africa Obsessive-Compulsive Disorder Medicine Sales Value by Country (%), 2023 VS 2030

Figure 38. Key Countries/Regions Obsessive-Compulsive Disorder Medicine Sales Value (%), (2019-2030)

Figure 39. Key Countries/Regions Obsessive-Compulsive Disorder Medicine Sales Volume (%), (2019-2030)

Figure 40. United States Obsessive-Compulsive Disorder Medicine Sales Value, (2019-2030) & (US$ Million)

Figure 41. United States Obsessive-Compulsive Disorder Medicine Sales Value by Type (%), 2023 VS 2030

Figure 42. United States Obsessive-Compulsive Disorder Medicine Sales Value by Application (%), 2023 VS 2030

Figure 43. Europe Obsessive-Compulsive Disorder Medicine Sales Value, (2019-2030) & (US$ Million)

Figure 44. Europe Obsessive-Compulsive Disorder Medicine Sales Value by Type (%), 2023 VS 2030

Figure 45. Europe Obsessive-Compulsive Disorder Medicine Sales Value by Application (%), 2023 VS 2030

Figure 46. China Obsessive-Compulsive Disorder Medicine Sales Value, (2019-2030) & (US$ Million)

Figure 47. China Obsessive-Compulsive Disorder Medicine Sales Value by Type (%), 2023 VS 2030

Figure 48. China Obsessive-Compulsive Disorder Medicine Sales Value by Application (%), 2023 VS 2030

Figure 49. Japan Obsessive-Compulsive Disorder Medicine Sales Value, (2019-2030) & (US$ Million)

Figure 50. Japan Obsessive-Compulsive Disorder Medicine Sales Value by Type (%), 2023 VS 2030

Figure 51. Japan Obsessive-Compulsive Disorder Medicine Sales Value by Application (%), 2023 VS 2030

Figure 52. South Korea Obsessive-Compulsive Disorder Medicine Sales Value, (2019-2030) & (US$ Million)

Figure 53. South Korea Obsessive-Compulsive Disorder Medicine Sales Value by Type (%), 2023 VS 2030

Figure 54. South Korea Obsessive-Compulsive Disorder Medicine Sales Value by Application (%), 2023 VS 2030

Figure 55. Southeast Asia Obsessive-Compulsive Disorder Medicine Sales Value, (2019-2030) & (US$ Million)

Figure 56. Southeast Asia Obsessive-Compulsive Disorder Medicine Sales Value by Type (%), 2023 VS 2030

Figure 57. Southeast Asia Obsessive-Compulsive Disorder Medicine Sales Value by Application (%), 2023 VS 2030

Figure 58. India Obsessive-Compulsive Disorder Medicine Sales Value, (2019-2030) & (US$ Million)

Figure 59. India Obsessive-Compulsive Disorder Medicine Sales Value by Type (%), 2023 VS 2030

Figure 60. India Obsessive-Compulsive Disorder Medicine Sales Value by Application (%), 2023 VS 2030

Figure 61. Obsessive-Compulsive Disorder Medicine Industrial Chain

Figure 62. Obsessive-Compulsive Disorder Medicine Manufacturing Cost Structure

Figure 63. Channels of Distribution (Direct Sales, and Distribution)

Figure 64. Bottom-up and Top-down Approaches for This Report

Figure 65. Data Triangulation

Figure 66. Key Executives Interviewed

KEY QUESTIONS ADDRESSED BY THE REPORT

Which companies rank high in the global Obsessive-Compulsive Disorder Medicine market? zhanKai

The top companies in the global Obsessive-Compulsive Disorder Medicine market are Sun pharmaceuticals industry Ltd.、H.Lunderbeck A/S、Eli Lilly and company.

Related Reports

Global Obsessive-Compulsive Disorder Medicine Market Research Report 2025
The global market for Obsessive-Compulsive Disorder Medicine was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Published Date: 2025-01-01
Pages: 100
USD 2900.00
(Single User License)
Global Obsessive-Compulsive Disorder Medicine Market Insights, Forecast to 2030
Obsessive–compulsive disorder (OCD) is a mental disorder in which a person feels the need to perform certain routines repeatedly (called "compulsions"), or has certain thoughts repeatedly (called "obsessions").
Published Date: 2024-04-18
Pages: 117
USD 4900.00
(Single User License)
Global Obsessive-Compulsive Disorder Medicine Market Research Report 2024
Obsessive–compulsive disorder (OCD) is a mental disorder in which a person feels the need to perform certain routines repeatedly (called "compulsions"), or has certain thoughts repeatedly (called "obsessions").
Published Date: 2024-01-16
Pages: 101
USD 2900.00
(Single User License)

Global Obsessive-Compulsive Disorder Medicine Market Research Report 2025
The global market for Obsessive-Compulsive Disorder Medicine was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Published: 2025-01-01
Pages: 100
USD 2900.00 (Single User License)
Global Obsessive-Compulsive Disorder Medicine Market Insights, Forecast to 2030
Obsessive–compulsive disorder (OCD) is a mental disorder in which a person feels the need to perform certain routines repeatedly (called "compulsions"), or has certain thoughts repeatedly (called "obsessions").
Published: 2024-04-18
Pages: 117
USD 4900.00 (Single User License)
Global Obsessive-Compulsive Disorder Medicine Market Research Report 2024
Obsessive–compulsive disorder (OCD) is a mental disorder in which a person feels the need to perform certain routines repeatedly (called "compulsions"), or has certain thoughts repeatedly (called "obsessions").
Published: 2024-01-16
Pages: 101
USD 2900.00 (Single User License)